HLA Molecules and Beyond
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 3714
Special Issue Editors
Interests: T cell; TCR; HLA; virus; peptide recognition and presentation; structural immunology; T cell activation and signalling; viral mutation and viral escape
Special Issues, Collections and Topics in MDPI journals
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia
Interests: comparative immunology; chemistry; structural biology; cell immunology; advanced atomic and molecular imaging; non-peptidic antigens; evolution; MHC-like antigen-presenting molecules
Interests: T cell; TCR; HLA; virus; peptide recognition and presentation; structural immunology; T cell activation and signalling; viral mutation and viral escape
Interests: T cell; TCR; HLA; virus; peptide recognition and presentation; structural immunology; T cell activation and signalling; viral mutation and viral escape
Special Issue Information
Dear Colleagues,
As the COVID-19 pandemic is crippling the world, the reservoir of pathogens that can be detrimental to human health is of utmost importance. This Special Issue is focusing on understanding the critical role and diversity of antigen-presenting molecules in humans and animals. The classical HLA molecules that present peptides are well-studied in this group, being able to activate the immune system and in turn control and determine the outcome of a given infection.
Since the first description and characterisation of peptide-binding HLA molecules in 1987, we have developed a deeper understanding of the diversity of the peptide repertoire (length, post-translational modification, motif, chemical properties) that the classical HLAs can present, as well as their corresponding immune response. In addition, we also know that antigen-presenting molecules can bind to lipids, small metabolites, or even drugs, and that with the further advances of comparative immunology, there is no doubt that new and uncharacterised ligands will be discovered.
A deep characterisation of those molecules and the type of ligand they are able to bind and present to the immune system is critical to understand the infection and outcome of a disease, to provide new therapeutics and vaccines, as well as understanding the fundamental interplay between the different molecules of the immune system.
Therefore, we are calling for research articles, reviews, and opinion pieces focusing on antigen presenting molecules encompassing HLA and beyond the classical HLA molecules.
Prof. Dr. Stephanie Gras
Dr. Jerome Le Nours
Dr. Dimitra Chatzileontiadou
Dr. Christopher Szeto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HLA-A, -B, -C, -E, -F, -G
- HLA class II
- MHC
- CD1
- MR1
- human immunology
- animal immunology
- antigen presenting molecule
- comparative immunology
- peptide antigen
- lipid antigen
- metabolite antigen
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
